BREAKING NEWS: FDA Approves Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer (read more here).
Go here to learn more or to get a mailed copy.
Home » Archives for April 2019
The feeling of helplessness brought upon a patient and those who love them is perhaps one of the worst parts of a prostate cancer diagnosis. Between the uncertainty of the...Read More
The phrase “cancer does not discriminate” gets thrown around quite a bit. It comes from a good place –– the idea that cancer is everyone’s problem and that whether you...Read More